These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31884593)

  • 1. Emerging Concepts for RNA Therapeutics for Inherited Retinal Disease.
    Moore SM; Skowronska-Krawczyk D; Chao DL
    Adv Exp Med Biol; 2019; 1185():85-89. PubMed ID: 31884593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense Oligonucleotide Therapy for Ophthalmic Conditions.
    Ferenchak K; Deitch I; Huckfeldt R
    Semin Ophthalmol; 2021 Aug; 36(5-6):452-457. PubMed ID: 34010086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases.
    Xue K; MacLaren RE
    Expert Opin Investig Drugs; 2020 Oct; 29(10):1163-1170. PubMed ID: 32741234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA therapeutics in ophthalmology - translation to clinical trials.
    Gupta A; Kafetzis KN; Tagalakis AD; Yu-Wai-Man C
    Exp Eye Res; 2021 Apr; 205():108482. PubMed ID: 33548256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene editing prospects for treating inherited retinal diseases.
    Benati D; Patrizi C; Recchia A
    J Med Genet; 2020 Jul; 57(7):437-444. PubMed ID: 31857428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele-specific antisense oligonucleotides for the treatment of BEST1-related dominantly inherited retinal diseases: An in vitro model.
    Karaosmanoglu B; Imren G; Utine E; Taylan Sekeroglu H; Taskiran EZ
    Exp Eye Res; 2024 Apr; 241():109833. PubMed ID: 38369231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential and mechanism of action of oligonucleotides and ribozymes.
    Lavrovsky Y; Chen S; Roy AK
    Biochem Mol Med; 1997 Oct; 62(1):11-22. PubMed ID: 9367793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA therapeutics for retinal diseases.
    Gemayel MC; Bhatwadekar AD; Ciulla T
    Expert Opin Biol Ther; 2021 May; 21(5):603-613. PubMed ID: 33307874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribozyme uses in retinal gene therapy.
    Hauswirth WW; Lewin AS
    Prog Retin Eye Res; 2000 Nov; 19(6):689-710. PubMed ID: 11029552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acid modulation of gene expression: approaches for nucleic acid therapeutics against cancer.
    Nakata Y; Kim TK; Shetzline S; Gewirtz AM
    Crit Rev Eukaryot Gene Expr; 2005; 15(2):163-82. PubMed ID: 16022634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants.
    von Weizsäcker F; Wieland S; Köck J; Offensperger WB; Offensperger S; Moradpour D; Blum HE
    Hepatology; 1997 Aug; 26(2):251-5. PubMed ID: 9252130
    [No Abstract]   [Full Text] [Related]  

  • 12. A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets.
    Yau EH; Butler MC; Sullivan JM
    Exp Eye Res; 2016 Oct; 151():236-55. PubMed ID: 27233447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-targeting strategies as a platform for ocular gene therapy.
    Kumar S; Fry LE; Wang JH; Martin KR; Hewitt AW; Chen FK; Liu GS
    Prog Retin Eye Res; 2023 Jan; 92():101110. PubMed ID: 35840489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic antisense and ribozymes.
    Rossi JJ
    Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.
    Sanjurjo-Soriano C; Kalatzis V
    Neural Plast; 2018; 2018():5056279. PubMed ID: 29853845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects for nucleic acid-based therapeutics against hepatitis C virus.
    Lee CH; Kim JH; Lee SW
    World J Gastroenterol; 2013 Dec; 19(47):8949-62. PubMed ID: 24379620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference (RNAi)-based therapeutics for treatment of rare neurologic diseases.
    Germain ND; Chung WK; Sarmiere PD
    Mol Aspects Med; 2023 Jun; 91():101148. PubMed ID: 36257857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense strategies in degenerative joint diseases: sense or nonsense?
    Huber LC; Distler O; Gay RE; Gay S
    Adv Drug Deliv Rev; 2006 May; 58(2):285-99. PubMed ID: 16574269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleic acids-based therapeutics in the battle against pathogenic viruses.
    Haasnoot J; Berkhout B
    Handb Exp Pharmacol; 2009; 189(189):243-63. PubMed ID: 19048203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and applications of modified oligonucleotides.
    Gallo M; Montserrat JM; Iribarren AM
    Braz J Med Biol Res; 2003 Feb; 36(2):143-51. PubMed ID: 12563516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.